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Abstract: Chitosan coated alginate beads containing poly(N-isopropylacrylamide) (PNI-
PAAM), were prepared to be used as a controlled pH/temperature sensitive drug delivery
system with improved encapsulation efficiency and delayed release rate. The studied beads
were characterized by differential scanning calorimetry, scanning electron microscopy, and
Fourier transform infrared spectroscopy. Water uptake and release studies using indometha-
cin as a model drug were also performed. The drug loading efficiency of the beads with the
polyelectrolyte complex coating is significantly higher (84%) than that of the uncoated ones
(74%). The equilibrium swelling of the developed materials was found to be pH- and thermo-
responsive. For all the conditions it was found that the release profile was slower for the coated
beads, indicating that the polyelectrolyte complex coating could slow down the release rate
effectively. These results suggest that the studied smart system has potential to be used as an
effective pH/temperature sustainable delivery system for biomedical applications. ' 2007 Wiley
Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 84B: 595–603, 2008
Keywords: alginate; biomaterials; chitosan; drug delivery systems; pH/temperature
responsive
INTRODUCTION
Recently, there has been a great deal of research activity in
the development of stimulus-responsive polymeric hydro-
gels. These hydrogels respond to external or internal stimuli
and the response can be observed through abrupt changes in
the physical nature of the network.1,2 Among these systems,
pH or temperature responsive hydrogels have been exten-
sively studied in the biomedical ﬁeld because these two fac-
tors can be easily controlled and applicable both in vitro and
in vivo conditions.3–5
Much research has been done to associate biopolymers
(such as alginate and chitosan) with thermo-sensitive macro-
molecules in an attempt to prepare matrixes that present a
dual and independent sensitivity to both pH and temperature.
Poly(N-isopropylacrylamide), PNIPAAM, is one of the most
widely studied temperature sensitive polymers, exhibiting a
temperature-dependent volume phase transition at lower crit-
ical solution temperature (LCST) around 328C.6–8 Many
studies concerning alginate/PNIPAAM dual responsive
hydrogels have been reported.5,9–11 However, relatively little
work has been reported on the potential of both pH and tem-
perature sensitivity in these systems, to control effectively
the delivery of bioactive agents. In fact, such systems pres-
ent both an independent and mutual inﬂuence of temperature
and pH on the swelling and drug release of the system.12–14
For instance, the presence of a thermo-responsive material
in the developed system affects itself the pH response
of the pH responsive material, even when the thermo-sensi-
tive material is above the LCST. Moreover, the LCST
can be adjusted to obtain a desired swelling/drug release
proﬁle.12–14
The temperature/pH responsive drug release behavior of
the calcium (Ca)-alginate/PNIPAAM semi-interpenetrating
(semi-IPN) beads were discussed in our former article.15
However, the relatively low drug encapsulation efﬁciency
and the high release rate of the Ca-alginate/PNIPAAM sys-
tem were the main limitations of this dual-stimuli-responsive
drug delivery system.
Chitosan, a polysaccharide derived from chitin by alka-
line deacetylation, has been proposed as a useful excipient
for either sustained release of water-soluble drugs and for
enhancing the bioavailability of poorly water-soluble com-
pounds. To achieve sufﬁcient stability, chitosan gel beads
are often chemically cross-linked with glutaraldehyde and
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ethylene glycol diglycidyl ether.16,17 However, residues of
theses compounds in the chitosan beads may induce undesir-
able side effects. Recently, polyelectrolyte complexes have
been proposed for the design of drug delivery systems.18–25
The term ‘‘polyelectrolyte’’ is used for polymers carrying
covalently bound anionic or cationic groups, and low molec-
ular ‘‘counterions’’ securing for electroneutrality.26 A poly-
electrolyte complex can be prepared by the formation of
complexes resulting from the interaction of oppositely
charged polyelectrolytes. For instance, cationic chitosan can
form gels with nontoxic multivalent anionic counterions,
such as polyphosphate and sodium alginate, by ionic interac-
tions.
In the present work, we prepared chitosan coated alginate
beads containing PNIPAAM based on the electrostatic interac-
tion between the carboxylate groups of alginate and the ammo-
nium groups of chitosan. This procedure is an attempt to
improve encapsulation efﬁciency and delay the release behav-
ior and by this way overcome the main limitations of the pre-
viously reported temperature and pH-responsive Ca-alginate/
PNIPAAM beads.15 Such effects of electrostatic barriers have
been reported by some authors for pH-responsive beads.18,19
On the other hand, as the beads described in this study contain
a chitosan coating it is necessary to analyze if their pH/temper-
ature response is different than the response corresponding to
the former system, which does not contain chitosan. So, the
equilibrium swelling behavior of these modiﬁed beads (com-
pared to unaltered alginate-PNIPAAM beads), as well as their
performance as a drug delivery system, is investigated as a
function of both pH and temperature. It should be mentioned
that the LCST of the developed systems, which is around
318C, could be adjusted to around 378C or even higher tem-
peratures in a future work. Such systems could be physiologi-
cally relevant, for instance, for targeted drug release of solid
tumors in the intestinal track: (1) the drug administrated orally
can bypass the acidity of gastric ﬂuids without liberating sub-
stantial amounts of drug and go into the intestinal ﬂuids (neu-
tral conditions); (2) the tumor is subjected to local
hyperthermia (typically between 37 and 428C), which triggers
drug release.
MATERIALS AND METHODS
Materials
N-isopropylacrylamide (NIPAAM, Acros Chem.), ammo-
nium persulfate (APS, Sigma Chem.), N,N,N0,N0-tetramethy-
lethylenediamine (TEMED, Sigma Chem.), ‘‘low viscosity’’
sodium alginate (viscosity of 2% solution at 258C ¼
250 cps, Sigma Chem.), chitosan (medium molecular
weight, 85% degree of deacetylation, Sigma Chem.), and in-
domethacin (Fluka Chem.) were used as received.
Synthesis of PNIPAAM
Poly(N-isopropylacrylamide), PNIPAAM, was prepared by
redox polymerization as reported elsewhere.10 Brieﬂy, an
aqueous solution was prepared by dissolving 35.3 mmol of
N-isopropylacrylamide and 1.35 mmol of ammonium persul-
fate in 45 mL deionized water. The solution was then purged
with nitrogen during 30 min to induce oxygen expulsion.
Afterwards, 0.267 mmol of TEMED was added. The poly-
merization was carried out at room temperature for 7 h.
After the reaction, the product was puriﬁed by precipitation
in hot water and dissolved in water repeatedly. The resultant
product was dried in air overnight and then vacuum dried at
408C for 24 h.
Preparation of Uncoated Beads
The aqueous solutions of 1.5% alginate (w/v) and PNI-
PAAM were mixed in the composition of PNIPAAM: algi-
nate ¼ 1:3 (w/w). About 20% (w/w) of indomethacin
(relatively to the total weights of alginate and PNIPAAM)
were added into the above solution. Thereafter, the solution
was extruded in the form of droplets using a syringe into 3%
CaCl2 (w/v) solution under stirring at 200 rpm. The smooth,
spherical, and homogenous beads obtained were kept for
30 min in CaCl2 solution under stirring. After crosslinking,
the beads were washed with deionized water repeatedly. The
resultant beads were dried in air overnight and then vacuum
dried at 408C for 24 h.
Preparation of Chitosan Coated Alginate Beads
The chitosan coated alginate beads were prepared based on
the procedure referred in other works.18,19 A homogeneous
mixture of 1.5% (w/v) sodium alginate, PNIPAAM [PNI-
PAAM: alginate ¼ 1:3 (w/w)], and 20% (w/w) of indometh-
acin (relatively to the total weights of alginate and
PNIPAAM) were dissolved in deionized water. The pH was
adjusted to 5.5 6 0.1 by adding HCl solution (1M) to the
earlier mixture. Homogeneous aqueous solutions of chitosan
in 1% (v/v) acetic acid (0.2% and 0.4%) containing 3%
CaCl2 were used as coagulation ﬂuid. The solution was
mixed for 1.5 h before use. The pH of the coagulation ﬂuids
was adjusted to 4.5 6 0.1 by adding NaOH solution (1M) to
the earlier coagulation ﬂuids. Thereafter, the mixture of algi-
nate, PNIPAAM, and indomethacin were extruded in the
form of droplets using a syringe into coagulation ﬂuid under
mechanical stirring at 200 rpm. The smooth, spherical, and
homogenous beads obtained were kept for 60 min in CaCl2
solution under stirring. The resultant beads were washed
once with deionized water and transferred into a 0.08% (w/
v) chitosan solution (previously obtained by dissolving 0.08
g of chitosan in 100 mL of 1% (v/v) acetic acid) for 30 min,
then incubated in a 0.08% (w/v) alginate solution (previ-
ously prepared by dissolving 0.08 g of alginate in 100 mL of
deionized water) for 30 min and at last put into 0.5% CaCl2
solution for 30 min. The beads were washed with deionized
water repeatedly. The resultant beads were dried in air over-
night and then vacuum dried at 408C for 24 h.
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Scanning Electron Microscopy
The morphology of the beads was examined by scanning
electron microscopy (SEM) (Leica Cambridge S 360) at an
accelerated voltage of 15 kV. Before being observed by
SEM, the beads were gold coated using a Hitachi coating
unit IB-2 coater at 6 mA.
Fourier Transform Infrared Spectroscopy
The Fourier transform infrared spectroscopy (FTIR) spectra
of the samples were recorded with a double-beam Perkin-
Elmer 1600 FTIR spectrometer in the range of 4000–
400 cm1 using KBr pellets.
Determination of LCST
Differential scanning calorimetry (DSC) measurements
(Setaram DSC 131) were conducted to determine the LCST
of the uncoated semi-IPN and coated semi-IPN beads. First,
all the beads were immersed in deionized water at room tem-
perature and allowed to swell for 24 h. Then, the DSC analy-
sis of the swollen beads was performed from 26 to 448C at
38C/min and under a nitrogen ﬂow of 20 cm3/min. Tempera-
ture and heat ﬂow calibrations were carried out using a pure
indium standard at the same heating rate of the experiments.
Swelling Studies
The swelling behavior of the beads was studied in phosphate
buffer solutions (PBS) with two different pH, 2.1 and 7.4
(similar to that of gastric and intestinal ﬂuids, respectively),
and at two temperatures, 25 and 378C. At predetermined
time intervals, the swollen beads were weighed after wiped
with soft paper tissue. The measurements were repeated at
least three times, for each condition. The degree of swelling
for each sample was calculated by using the following
expression: Swelling ratio ¼ (Ws  Wd)/Wd, where Ws and
Wd are the weight of the swollen beads and that of the dried
beads, respectively.
Determination of Indomethacin Encapsulation
Efﬁciency of the Beads
The beads (10 mg) were dissolved in 100 mL of PBS (pH
7.4, containing 5% (v/v) ethanol) under stirring during 24 h.
The amount of free indomethacin was determined in the
clear supernatant by UV spectrophotometry at 320 nm using
a calibration curve constructed from a series of indometha-
cin solutions with standard concentrations. Such experiments
allow the calculation of both the loading efﬁciency and the
loading content. The loading efﬁciency is deﬁned as the
weight percentage of loaded drug based on feed amount and
the loading content is the weight percentage of drug rela-
tively to the beads.
In Vitro Release Studies
The beads (10 mg) were suspended in 50 mL of PBS (pH
7.4 or 2.1). This dissolution medium was stirred at 50 rpm in
a horizontal laboratory shaker and maintained at 378C or
258C. The sample (2 mL) was periodically removed and the
withdrawn sample was replaced by the same volume of fresh
medium. These experiments were performed at least three
times. The amount of released indomethacin was analyzed
with a spectrophotometer as described previously.
RESULTS
Characterization of the Beads
Three kinds of beads were prepared as listed in Table I. The
wet beads just after preparation were found to be globular in
shape; but upon drying in air at room temperature the sphe-
ricity was very much lost, as it is evident from SEM result
of dried beads (Figure 1). It can be noted from Figure 1 that
the beads are about 800–1000 mm in size and not spherical
in shape. It appeared that the incorporation of chitosan in the
Ca-alginate/PNIPAAM beads has greatly altered the surface
texture of the beads [Figure 1(c–f)], when compared with
the uncoated beads [Figure 1(a,b)]. For the uncoated beads
[Figure 1(a,b)], the surface is found to be rougher than for
the coated ones.
Figure 2 shows the FTIR spectra for alginate, chitosan,
and the studied beads. By looking at Figure 2, it can be seen
that the chemical structure of the beads is similar to alginate,
which is the major fraction in the composition of the beads.
For the studied beads, the characteristic peak of PNIPAAM
at 1650 cm1 (amide I) cannot be observed because of the
strong peak of alginate at 1620 cm1, but a shoulder peak
can be found at 1540 cm1 associated to the amide II group
of PNIPAAM. Additionally, the peak that appeared at
1365 cm1 was assigned to the methyl group of PNI-
TABLE I. Composition, LCST, and Drug Loading Efﬁciency of the Studied Beads
Sample
Chitosan
Concentration
in Coagulation
Fluid (%) LCSTa (8C)
Drug
Percent
(Feed, %)
Drug Content
(mg/10 mg
Beads)
Loading
Content (%)
Loading
Efﬁciency (%)
A uncoated 30.7 6 0.1 20 1.24 6 0.03 14.8 6 0.23 74.2 6 1.15
B 0.2 31.1 6 0.1 20 1.41 6 0.03 16.9 6 0.27 85.6 6 1.20
C 0.4 31.1 6 0.2 20 1.40 6 0.02 16.8 6 0.21 83.8 6 1.05
adetermined by DSC measurements.
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PAAM.27 The peaks at 1688 cm1 and 1070 cm1, which
can be seen for the coated beads, are due to the presence of
chitosan (see Discussion Section).
It can be observed from Table I that the loading efﬁciency
of the uncoated beads is around 74%, while the values for
the two coated beads are all around 84%. The drug within
the coated beads seems to be more tightly entrapped as a
result of the strong complex formed between the carboxylate
groups of alginate and the protonated amine groups of chito-
san.
LCST of the Beads
The LCST of the studied beads was determined by DSC
measurements (Figure 3). The values of the onset tempera-
ture of the peaks (deﬁned as LCST) are shown in Table I.
The LCST was found to be around 318C for all the beads,
which is very close to the LCST of pure PNIPAAM. We
also observed that the color of the studied beads in PBS (pH
Figure 1. SEM micrographs of uncoated beads (a) and its surface morphology (b), chitosan (0.2%)
coated alginate beads (c) and its surface morphology (d), chitosan (0.4%) coated alginate beads (e)
and its surface morphology (f).
Figure 2. FTIR spectra of the studied semi-IPN beads (see Table I
for the correspondence of the codes A, B, and C).
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7.4) turned from almost colorless to white, when the temper-
ature increased from below the LCST to above the LCST;
this is in line with previous observations in similar sys-
tems.9,15
Swelling Study
Figure 4 shows the swelling behavior of the beads at differ-
ent pH values and temperatures. The coated beads have a
swelling property similar to alginate, since the fraction of al-
ginate in the resultant beads is much higher than chitosan (as
demonstrated by FTIR results). Figure 4 shows an obviously
higher swelling degree at higher pH for all the beads. The
mean values (and standard deviations) corresponding to
the distinct samples can be found in Table II. Regarding
the modiﬁcations in the swelling behavior after coating
(Table II and Figure 4) it can be observed that the swelling
ratio at pH 7.4 changes from 30% to 41% (258C) and
from 32% to 48% (378C); at pH 2.1 the swelling ratio
increases from 11% to 16% (either at 258C or 378C).
Analysis by a Student’s t-test showed that the differences
between the swelling ratio of the coated and uncoated beads
are statistically signiﬁcant (greater than 95% conﬁdence)
both at pH 7.4 and 2.1. The p values were in the range
0.001–0.005 at pH 7.4 and varied between 0.02 and 0.04 at
pH 2.1. So, we can say that the swelling ratio of the coated
beads is higher than the one corresponding to the uncoated
ones both at pH 7.4 and 2.1. Moreover, at pH 7.4 the swel-
ling ratio of the coated beads is signiﬁcantly higher at 378C
than at 258C. Regarding the coated beads, the small differen-
ces in their swelling behavior are not statistically signiﬁcant
(p value > 0.1).
An interesting property of the coated beads observed in
our experiments is that they could keep intact during
240 min at pH 7.4 even though the swelling ratio is very
high, while the uncoated beads can only maintain their integ-
rity for about 180 min at the same conditions.
Drug Release Study
Figure 5 shows the indomethacin release proﬁles of the stud-
ied beads at 378C and pH 7.4. These results suggest that the
amount of indomethacin released can be delayed in the
coated beads. A Student’s t-test analysis was conducted to
support the previous statement. The p values obtained in the
comparison between the data of sample A and sample B or
C were in the range 0.001–0.048 for the time period between
60 and 180 min, i.e., the difference between the data of sam-
ple A and samples B/C is statistically signiﬁcant (greater
than 95% conﬁdence) for the considered time period. The
release amount reaches 90% within 180 min for the uncoated
beads, while a drug release of 90% will take almost 270 min
for the coated beads.
Figure 6 presents the drug release behavior at 378C for all
the samples at pH 2.1 and pH 7.4. A signiﬁcant pH-depend-
Figure 3. Temperature dependence of the normalized heat ﬂow for
the studied beads (see Table I for the correspondence of the codes
A, B, and C) as studied by DSC from heating experiments at 38C/
min.
Figure 4. Temperature- and pH- dependent changes of equilibrium
swelling ratio for the studied beads (see Table I for the correspon-
dence of the codes A, B, and C).
TABLE II. Temperature- and pH- Dependent Changes of
Equilibrium Swelling Ratio for the Studied Beads
pH 7.4 pH 2.1
258C 378C 258C 378C
A
Average value 30.0 32.0 11.0 11.5
Standard deviation 1.7 1.9 0.6 1.0
B
Average value 41.5 49.5 16.6 15.3
Standard deviation 1.7 2.1 1.1 1.2
C
Average value 41.0 46.5 16.1 15.2
Standard deviation 1.9 2.2 1.0 0.9
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ent response can be observed for both coated beads, which is
similar to the release behavior of the uncoated ones
described in a previous article.15 The release behavior at pH
2.1 is characterized by an initial burst after which a very
slow release is observed. It can also be noted from Figure 6
that the release amount of the coated beads (about 3%) is
lower than for the uncoated one (about 10%) at pH 2.1.
Analysis by a Student’s t-test showed that the differences
between these results are statistically signiﬁcant. The p val-
ues obtained in the comparison between the data of sample
A and sample B/C were in the range 0.0003–0.04. It should
be pointed that indomethacin solubility in acidic conditions
is much lower than in neutral solutions. Therefore besides
the response of alginate to pH, clearly detected in swelling
(Figure 4), the release proﬁle may also be dependent on pH
due to the different solubility of indomethacin.28
Figure 7 shows the drug release proﬁles from samples in
a buffer solution of pH 7.4 at 378C and 258C. A temperature
dependent response can be observed for both coated beads:
higher release rates are obtained at 378C, while lower release
rates can be observed at 258C. It can also be observed that
for the coated beads the drug release rate seems to be lower
than for the uncoated one at pH 7.4 and 258C. Student’s t-
test analysis showed that the difference between the release
of sample A and samples B and C is statistically different
for times higher than 180 min (p values between 0.002 and
0.03). For the referred time period, the drug release was 7–
25% higher for sample A than for samples B and C.
It should be pointed that no statistically signiﬁcant differ-
ences were found in the drug release behavior at different
pH and temperatures between the two coated beads (p value
> 0.1).
DISCUSSION
Characterization of the Beads
The change in the texture of the outer surface for the coated
beads [Figure 1(c–f)] when compared with the texture of the
uncoated ones [Figure 1(a,b)] should be related to the forma-
tion of a polyelectrolyte complex coating between alginate
and chitosan. We expect that this skin layer could reduce the
loss of entrapped indomethacin during the preparation pro-
cess, delaying the release of the drug in the following drug
release experiments. The roughness observed for the
uncoated beads probably results from the aggregation of in-
domethacin. Moreover, it seems that the surface texture of
the coated beads is not affected by the different chitosan
concentrations used in this study, because there are no
obvious differences between Figures 1d and 1f.
Compared to the characteristic adsorption peaks of algi-
nate and chitosan from the FTIR spectra of studied beads
Figure 5. Release proﬁles of indomethacin from the studied beads
(see Table I for the correspondence of the codes A, B, and C)
measured at 378C and pH 7.4.
Figure 6. pH-dependent release proﬁles of indomethacin at 378C
from the studied beads (see Table I for the correspondence of the
codes A, B, and C) measured at pH 2.1 and 7.4.
Figure 7. Temperature-dependent release proﬁles of indomethacin
from the studied beads (see Table I for the correspondence of the
codes A, B, and C) at pH 7.4 measured at 258C and 378C.
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(Figure 2), one can easily ﬁnd that the chemical structure of
the beads is similar to alginate. This result indicated that
most of the bound chitosan was accumulated only at the sur-
face due to the hindrance of macromolecular chitosan from
further diffusing into the inner core.20 For the uncoated
beads (sample A), the characteristic peak of alginate is seen
at 1620 cm1 corresponding to the carbonyl (C¼O) bond.
After coating, the peak of 1620 cm1 was replaced by a new
broad band (1601 cm1), as a result of the interaction
between the negatively charged COO groups of alginate
(cross-linked with CaCl2) and the positively charged
NH3þ groups of chitosan. Additionally, two new peaks at
1688 cm1 and 1070 cm1 can be seen for all the coated
beads, which can be explained in terms of the unreacted chi-
tosan.22,29 These peaks are derived, respectively, from the
peaks of 1665 cm1 and 1079 cm1 of chitosan. The slight
shifts in the position of these peaks for the coated samples
could be attributed to the electrostatic interaction between
the carboxylate groups of alginate and the ammonium
groups of chitosan after reaction. These results suggest the
formation of a chitosan-alginate complex as a result of the
ionic interaction.
As suggested from SEM results (Figure 1), the drug on
the outer surface of the beads is covered by the polyelectro-
lyte complex membrane, which inhibits the loss of the
entrapped drug during the gelling and washing processes. As
a result, more indomethacin could remain in the beads. An
increased load of other drugs in chitosan-coated alginate
beads has also been reported.18,19,23,30 It can also be noted
from Table I that the chitosan concentration has little effect
on the loading efﬁciency. So, the electrostatic interaction
between chitosan and alginate tightens and stabilizes the sur-
face of the beads. This means that polyelectrolyte complex
coatings can improve the encapsulation yield effectively in
such kind of systems.
LCST of the Beads
When a swollen PNIPAAM hydrogel is heated above the
LCST, the PNIPAAM chains collapse and this is accompa-
nied by a drastic contraction of the gel.6,8 This behavior can
be explained by the reversible formation (below LCST) and
cleavage (above LCST) of the hydrogen bonds between
NH and C¼O groups of PNIPAAM chains and the sur-
rounding water molecules.31 The LCST results listed in
Table I indicates that there is no chemical bond or other
strong interactions between the PNIPAAM fraction and the
other components of the system, which could change the bal-
ance between hydrophobic and hydrophilic interactions in
PNIPAAM.
The studied beads in PBS (pH 7.4) turned from colorless
to white when temperature changed from 25 to 378C. It was
suggested that the formation of the white core region gener-
ated above the LCST was due to the collapse and shrinkage
of the PNIPAAM network out of the semi-IPN composite
structure, which could lead to an increase of light diffusion.9
The presence of nearby physically entangled alginate and
chitosan polyelectrolyte complex chains do not affect the
collapse of the PNIPAAM chain network above the LCST.
Swelling Study
In the low pH region (pH 2.1) most of the carboxylic acid
groups in alginate are in the form of COOH, as the pKa of
alginate is about 3.2. The hydrogen bonds between COOH
in alginate and CONH in PNIPAAM leads to polymer–
polymer interactions predominating over the polymer–water
interactions. As a result, the swelling ratio of the studied
beads is relatively low. When the pH of the medium is
changed to 7.4 the carboxylic acid groups become ionized
and a small quantity of Hþ in water acts as the bridge among
alginate, resulting in the increase of the swelling ratio.32 The
higher swelling ratio presented by the coated beads when
compared with the uncoated ones, independently of pH or/
and temperature values is attributed to the presence of chito-
san at the surface. In fact chitosan by itself presents
extremely high swelling and water uptake capabilities
(140% at neutral pH) as the work of Silva et al.33 Also, a
high temperature can help the water to penetrate into the
semi-IPN beads, which contributes to the higher swelling ra-
tio of the coated beads at 378C when compared with their
swelling at room temperature. Such observations have been
already reported before.15
Drug Release Study
A slight, but signiﬁcant, delay in the drug release can be
observed for the coated beads at 378C and pH 7.4 (Figure 5).
This result is distinct from the results reported in other stud-
ies for chitosan-coated alginate beads without PNI-
PAAM,18,19,22,23 which revealed that the drug release could
be signiﬁcantly delayed after coating. We expect that the dif-
ference in the release proﬁle could be more evident in beads
coated with more layers.34 It was also observed no signiﬁ-
cantly different drug release behavior at 378C and pH 7.4 for
beads coated with different chitosan concentration.
The relatively low release amount of the studied beads at
pH 2.1 (Figure 6) should be related to the low degree of
swelling ratio of the beads in acidic conditions as shown in
Figure 4. Although we did not expect the contribution of chi-
tosan coating, which should dissolve at pH 2.1, we were
able to observe that the coated beads exhibit a slightly
slower release proﬁle. The amount of released drug at pH
7.4 increases signiﬁcantly (about 95% within 450 min),
which can be related to the higher swelling ratio at neutral
pH compared to pH 2.1 (Figure 4). The relatively low
release amount of the coated beads (about 3%, compared to
10% for the uncoated ones) at pH 2.1 is attributed to the
polyelectrolyte complex coating. So, although chitosan itself
is expected to dissolve at pH 2.1, its dissolution may not be
complete when it forms a physical network with alginate
and/or PNIPAAM, and thus, can still provide the release bar-
rier. Therefore, in an ingestible pharmaceutical application,
601CHITOSAN COATED ALGINATE/PNIPAAM BEADS FOR DRUG DELIVERY SYSTEMS
Journal of Biomedical Materials Research Part B: Applied Biomaterials
DOI 10.1002/jbmb
the coated beads are more efﬁcient than the uncoated ones to
bypass the acidity of gastric ﬂuid without liberating substan-
tial amounts of the loaded drug.
Regarding the results of Figure 7, the main reason to
explain the higher release rate at 378C and pH 7.4 is the pre-
cipitation of PNIPAAM above LCST, which leads to the
squeezing out of the drug.8,15,19 Additionally the swelling ra-
tio of the coated beads is higher at 378C than at 258C as
described in Figure 4, which can also result in a higher drug
release rate. It was also found that for the coated beads the
coating effectively decreases the drug release rate at pH 7.4
and 258C.
It must be noted that the drug release results presented
here were obtained with beads prepared with an alginate of
low viscosity and low molecular weight (2 wt % ¼ 250 cps).
In fact, different results would be probably obtained if an al-
ginate with a higher viscosity at 2 wt % (higher molecular
weight) is used, because it is expected that the resulting var-
iations in the molecular pore structure would affect the indo-
methacin diffusion. In terms of viscosity, it should be
mentioned that to prepare such kind of beads (coated or
uncoated) it is easier to use a low viscosity alginate (with
values close to the one referred in the experimental section),
otherwise it will be very difﬁcult to extrude the mixture of
alginate, PNIPAAM, and model drug with a syringe, in the
form of droplets.
CONCLUSIONS
A pH/temperature sensitive drug delivery system, based on
chitosan coated alginate beads containing PNIPAAM, was
successfully prepared. The chitosan coating could (i)
increase the loading efﬁciency and (ii) marginally decrease
the release rate. Despite the chitosan coating, the alginate/
PNIPAAM beads maintained the pH- and thermo- respon-
sive behavior. The results obtained in this work could be
useful in the development of smart hydrogels for controlled
release of bioactive agents or for tissue engineering applica-
tions.
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